在心脏骤停期间上腺素的药理动力学:试点研究
Bård E Heradstveit1, Geir-Arne Sunde1, Helge Asbjørnsen1
1Department of Anaesthesia and Intensive Care, Haukeland University Hospital, 5021 Bergen, Norway.
Resuscitation
|November 4, 2024
概括
在心脏骤停期间,上腺素的排泄时间会延长,重复剂量可能会增加血水平. 需要进一步的研究来确定最佳的复苏度.
科学领域:
- 心脏病学 心脏病学
- 药理学 药理学是指药理学的学科.
- 紧急医疗 紧急医疗
背景情况:
- 推在心脏骤停时使用上腺素,改善自发循环的恢复,但不能改善长期生存.
- 上腺素降低大脑血流的副作用凸显了其复杂的作用.
- 在心脏骤停期间上腺素的药理动力学仍未得到充分研究.
研究的目的:
- 在心脏骤停患者中调查上腺素的药理动力学.
- 测量一次性注射后上腺素的血度.
- 为了评估心脏骤停期间上腺素的消除半衰期.
主要方法:
- 九名心脏骤停患者接受了静脉注射一次1毫克剂量的上腺素.
- 每分钟从关静脉收集血液样本,以测量血中的度.
- 使用混合效应模型估计了消除半衰期 (T1/2).
主要成果:
- 八名患者的数据在一个排除后适合分析.
- 估计的消除率为-0.259 (95% CI: -0.361至-0.157).
- 上腺素的计算消除半衰期为2.6分钟 (95%CI:1.9至4.4分钟).
结论:
- 在心脏骤停患者中,上腺素的排泄显著延长.
- 重复使用上腺素剂量可能会导致血水平升高并具有潜在的毒性.
- 需要进行进一步的大规模研究,以确定在复苏期间最佳的上腺素剂量和血度.
相关概念视频
Adrenergic Agonists: Therapeutic Uses
731
Adrenergic agonists have diverse therapeutic uses across various medical conditions and emergencies.
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
731
Adrenergic Agonists: Mixed-Action Agents
669
Mixed-action adrenergic agonists, like ephedrine and pseudoephedrine, directly and indirectly affect adrenergic receptors. These agents stimulate adrenoceptors and indirectly release stored neurotransmitters, amplifying the adrenergic response.
Ephedrine and pseudoephedrine lack a catecholamine group, making them less susceptible to degradation by metabolic enzymes. They have increased oral bioavailability and lipophilicity, resulting in a longer duration of action. Their response is reduced by...
Ephedrine and pseudoephedrine lack a catecholamine group, making them less susceptible to degradation by metabolic enzymes. They have increased oral bioavailability and lipophilicity, resulting in a longer duration of action. Their response is reduced by...
669
Cardiac Action Potential
1.0K
Cardiac action potentials are essential for proper heart function, enabling the rhythmic contractions needed for adequate blood circulation. Nodal cells and Purkinje fibers, specialized for electrical conduction, generate these action potentials.
The cardiac action potential process involves a series of phases characterized by the movement of ions across the cardiac cell membranes, leading to the depolarization and repolarization of the cardiac myocytes.
Ionic Basis of Cardiac Action Potentials
The cardiac action potential process involves a series of phases characterized by the movement of ions across the cardiac cell membranes, leading to the depolarization and repolarization of the cardiac myocytes.
Ionic Basis of Cardiac Action Potentials
1.0K
Adrenergic Neurons: Neurotransmission
3.4K
Postganglionic sympathetic fibers (except those supplying the sweat glands) releasing noradrenaline or norepinephrine are called noradrenergic or adrenergic neurons. Noradrenaline, dopamine, adrenaline, or epinephrine are collectively called "catecholamines" as they contain a catechol moiety and an amine side chain. The five stages of neurotransmitter release involve their synthesis, storage, release, reuptake and metabolism.
Synthesis: Catecholamine synthesis requires tyrosine, which...
Synthesis: Catecholamine synthesis requires tyrosine, which...
3.4K
Depolarizing Blockers: Pharmocokinetics
310
Depolarizing blockers are administered through intravenous injection. Succinylcholine is the most common choice of depolarizing blockers in emergency clinical practices. Although they have a rapid onset, they readily diffuse away from the motor end plate into the extracellular fluid. They are metabolized by enzymes such as liver butyrylcholinesterase and plasma pseudocholinesterases. This produces a short duration of action, typically 5-10 minutes long, unlike nondepolarizing blockers, which...
310
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
709
Adrenergic stimulation generally impacts cardiac rate and rhythm. Specifically, stimulation of the β-adrenoceptors triggers an increase in intracellular calcium ion influx and pacemaker currents, which may cause arrhythmias. Catecholamines like adrenaline also demonstrate β2-adrenoceptor-mediated hypokalemia, impacting cardiac action potential and disrupting the normal cardiac rhythm. Class II antiarrhythmic drugs are β-adrenoceptor antagonists or β-blockers, which...
709


